Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DNA-mutation Analysis by Next Generation Sequencing in Cyst Fluid of Suspected Intraductal Papillary Mucinous Neoplasia of the Pancreas Obtained by Endoscopic Ultrasound-guided Fine Needle Aspiration (ZYSTEUS-Study)

NCT03820531 is registered in ClinicalTrials.gov with Theresienkrankenhaus und St. Hedwig-Klinik GmbH as lead sponsor.

NCT NCT03820531
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03820531 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DNA-mutation Analysis by Next Generation Sequencing in Cyst Fluid of Suspected Intraductal Papillary Mucinous Neoplasia of the Pancreas Obtained by Endoscopic Ultrasound-guided Fine Needle Aspiration (ZYSTEUS-Study)
Lead sponsor
Theresienkrankenhaus und St. Hedwig-Klinik GmbH
Phase
Not applicable
Overall status
Completed
Start date
January 1, 2018
Completion date
December 1, 2022
Enrollment
150 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreas cyst